Status:
NOT_YET_RECRUITING
Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Brain Metastases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the clinical usefulness of dynamic \[18F\]FDG PET imaging in assessing brain metastasis post stereotactic radiotherapy to separate true progression from the tr...
Detailed Description
After being informed about the study and potential risk, all participants giving written informed consent will be screened to determine if participant being referred fits eligibility criteria for the ...
Eligibility Criteria
Inclusion
- Age 18 or older.
- Willing and able to provide consent.
- ECOG 0-2.
- Life expectancy ≥12 months.
- Creatinine clearance ≥30 ml/min within 28 days prior to registration.
- At the discretion of the treating oncologist, it is believed that at least 1 lesion (or resection cavity) is best managed with SRS/SFR
Exclusion
- Pregnant or nursing women.
- Men or women of childbearing potential who are unwilling to employ adequate contraception.
- Inability to complete a brain MRI.
- Known allergy to gadolinium.
- Inability to complete a PET scan.
- Uncontrolled diabetes mellitus.
- Primary germ cell tumour, primary CNS tumour, or lymphoma
- SRS/FSRT is no longer indicated for any BMs
- Must be able to read and write English
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06511323
Start Date
August 1 2024
End Date
August 1 2027
Last Update
July 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.